Brief: Atara Biotherapeutics Inc - Entered Fourth Amendment With Pierre Fabre - SEC Filing
02/01/2026 22:11
Jan 2 (Reuters) - Atara Biotherapeutics Inc ATRA.O: ATARA BIOTHERAPEUTICS INC - ENTERED FOURTH AMENDMENT WITH PIERRE FABRE - SEC FILING ATARA BIOTHERAPEUTICS INC - MILESTONE PAYMENTS REDUCED FROM $40 MILLION TO $31 MILLION - SEC FILING Source text: [ID:n0001193125-26-000907] Further company coverage: ATRA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atara Biotherapeutics
See all newsBrief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing
Atara Biotherapeutics Q1 revenue drops after prior-year one-time gain
Brief: Atara Biotherapeutics Q1 EPS USD -0.29
NASDAQ RESUMED AT 03:40 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:30 PM